Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CAI stock hub

Caris Life Sciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CAIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.6B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CAI

In the news

Latest news · CAI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E85.7

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE28.4

P25 -105.6P50 -46.5P75 -3.1

ROIC12.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CAI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002019410
Company name	Caris Life Sciences, Inc.
Country	United States
Country code	US
Cusip	142152107
Employees	1,846
Employees Change	77%
Employees Change Percent	4.35
Enterprise value	$4.2B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2025-06-18
Isin	US1421521071
Last refreshed	2026-05-10
Market cap	$4.6B
Market cap category	Mid-Cap
Price	$16.15
Price currency	USD
Rev Per Employee	491,490.79x
Sector	Healthcare
Sic	8071
Symbol	CAI
Website	https://www.carislifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.01%
EV Sales Forward	3.85x
EV/EBIT	38.46x
EV/EBITDA	32.3x
EV/FCF	33.75x
EV/Sales	4.59x
FCF yield	2.7%
Forward P/E	85.68x
P/B ratio	7.69x
P/S ratio	5.03x
PS Forward	4.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.94%
EBITDA Margin	14.22%
FCF margin	13.61%
Gross margin	68.92%
Gross Profit	$625.3M
Gross Profit Growth	195.83%
Gross Profit Growth Q	147.71%
Net Income	$-411.4M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	3.73%
Profit Margin	3.75%
Profit Per Employee	$-222,873
ROA	9.31
ROCE	10.64
ROE	28.35
ROIC	12.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	2
Revenue Growth	100.51x
Revenue Growth Q	78.78x
Revenue Growth Quarters	5x
Revenue Growth Years	2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.25
Assets	$1.2B
Cash	$823.5M
Current Assets	$1B
Current Liabilities	$143.9M
Debt	$425.2M
Debt EBITDA	$3.04
Debt Equity	$0.72
Debt FCF	$3.44
Equity	$593.5M
Interest Coverage	1.9
Liabilities	$568.9M
Long Term Assets	$148.2M
Long Term Liabilities	$425M
Net Cash	$398.3M
Net Cash By Market Cap	$8.72
Net Debt EBITDA	$-3.09
Net Debt Equity	$-0.67
Net Debt FCF	$-3.23
Tangible Book Value	$574.1M
Tangible Book Value Per Share	$2.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.05
Inventory Turnover	5
Net Working Capital	$47M
Quick ratio	6.35
Working Capital	$870.3M
Working Capital Turnover	$2.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-543.56%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	26.25
50-day SMA	19.08
50-day SMA vs 200-day SMA	50under200
All Time High	42.5
All Time High Change	-62%
All Time High Date	2025-08-22
All Time Low	15.71
All Time Low Change	2.8%
All Time Low Date	2026-05-08
ATR	1.29
Beta1y	1.85
Ch YTD	-40.14
High	17.39
High52	42.5
High52 Date	2025-08-22
High52ch	-62%
Low	15.71
Low52	15.71
Low52 Date	2026-05-08
Low52ch	2.8%
Ma50ch	-15.35%
Premarket Change Percent	-14.57
Premarket Price	$16.95
Premarket Volume	30,624
Price vs 200-day SMA	-38.47%
RSI	35.74
RSI Monthly	0
RSI Weekly	36.03
Sharpe ratio	-0.77x
Sortino ratio	-0.93
Total Return	-543.56%
Tr YTD	-40.14
Tr1m	-13.87%
Tr1w	-12.56%
Tr3m	-26.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	12
Analyst Count Top	2
Analyst Price Target Top	$24.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.02
Earnings Revenue Estimate	209,494,568x
Earnings Revenue Estimate Growth	73.26x
Operating Income	$108.3M
Operating margin	11.94
Price target	$29.17
Price Target Change	$80.62
Price Target Change Top	$51.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96,539,546%
Float Percent	34.15%
Net Borrowing	27,741,000
Shares Insiders	48.36%
Shares Institutions	44.1%
Shares Out	282,662,545
Shares Qo Q	-4.57%
Shares Yo Y	543.56%
Short Float	12.21%
Short Ratio	4.48
Short Shares	4.17

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$52.3M
Average Volume	2,130,444.1x
Bv Per Share	2.1
CAPEX	$-23.9M
Ch1m	-13.87
Ch1w	-12.56
Ch3m	-26.59
Ch6m	-36.94
Change	-18.6%
Change From Open	-3.87
Close	19.84
Days Gap	-15.32
Depreciation Amortization	20,635,000
Dollar Volume	143,322,141.4
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$108.3M
EBITDA	$129M
EPS	$-1.8
F Score	5
FCF	$123.5M
FCF EV Yield	2.96x
FCF Per Share	$0.44
Financing CF	664,528,000
Fiscal Year End	December
Founded	2,008
Goodwill	19,344,000
Income Tax	$-134,000
Investing CF	-23,913,000
Ipr	-23.1
Iprfo	-40.19
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-03
Ma150	24
Ma150ch	-32.7%
Ma20	19.54
Ma20ch	-17.34%
Net CF	788,100,000
Next Earnings Date	2026-08-11
Open	16.8
Optionable	Yes
P FCF Ratio	36.98
P OCF Ratio	30.98
Position In Range	26.19
Post Close	16.15
Postmarket Change Percent	0.25
Postmarket Price	$16.19
Ppne	82,669,000
Pre Close	19.84
Price Date	2026-05-08
Price EBITDA	$35.39
Ptbv Ratio	7.95
Relative Volume	4.17x
Revenue	907,292,000x
SBC By Revenue	7.85x
Share Based Comp	71,187,000
Tax By Revenue	-0.01x
Tr6m	-36.94%
Us State	Texas
Volume	8,874,436
Z Score	7.03

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CAI pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns CAI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.1%

Float: +34.2% of shares outstanding

Insider ownership

+48.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CAI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

35.7

Neutral momentum band

Price vs 200-day MA

-38.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CAI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CAI stock rating?

Caris Life Sciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CAI analysis?

The full report lives at /stocks/CAI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CAI?

The latest report frames CAI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CAI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.